The Rise and Fall of Marcus Smith

The base just got picked up on Marcus Smith on Friday because I you know I watch it every week and it is straddling that line so it's going to be interesting to see if it can power through. One other thing that sticks out to me on this is that the the R&D is 41.4% that's that's prettyPretty high for a biotech stock right but they're putting a lot of a lot of that revenue back into the research and development side yeah. If you are do not want to be a paid subscriber you can totally use it for free and you just have to watch the ads you pay for it by watching the ads so you can play with that you